Kinetic Concepts, Cephalon and Pfizer Comprise Largest Healthcare Positions of This Fund Manager

Wall St. Watchdog reveals information regarding Millennium Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 250 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $1.055 billion.

Kinetic Concepts Inc. (NYSE:KCI): On 06/30/2011, Millennium Management reported holding 111,536 shares with a market value of $6,427,820. This comprised 0.06% of the total portfolio. On 09/30/2011, Millennium Management reported holding 748,306 shares with a market value of $49,305,882. This comprised 0.58% of the total portfolio. The net change in shares for this position over the two quarters is 636,770. About Company: Kinetic Concepts, Inc. designs, manufactures, markets, and services products that accelerate the healing process or prevent complications of wounds. The Company’s products include specialty hospital beds, and mattress replacements.

Cephalon Inc. (NASDAQ:CEPH): On 06/30/2011, Millennium Management reported holding 232,807 shares with a market value of $18,601,280. This comprised 0.17% of the total portfolio. On 09/30/2011, Millennium Management reported holding 532,195 shares with a market value of $42,948,135. This comprised 0.51% of the total portfolio. The net change in shares for this position over the two quarters is 299,388. About Company: Cephalon, Inc. is an international biopharmaceutical company that discovers, develops, and markets biopharmaceutical products to treat neurological disorders, pain, and cancer. The Company’s products include a product that treats excessive daytime sleepiness associated with narcolepsy.

Pfizer Inc. (NYSE:PFE): On 06/30/2011, Millennium Management reported holding 515,401 shares with a market value of $10,617,261. This comprised 0.1% of the total portfolio. On 09/30/2011, Millennium Management reported holding 1,667,715 shares with a market value of $29,485,202. This comprised 0.35% of the total portfolio. The net change in shares for this position over the two quarters is 1,152,314. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.

St. Jude Medical Inc. (NYSE:STJ): On 06/30/2011, Millennium Management reported holding 415,601 shares with a market value of $19,815,856. This comprised 0.18% of the total portfolio. On 09/30/2011, Millennium Management reported holding 783,217 shares with a market value of $28,344,622. This comprised 0.33% of the total portfolio. The net change in shares for this position over the two quarters is 367,616. About Company: St. Jude Medical, Inc. develops, manufactures, and distributes medical devices for the worldwide cardiovascular market. The Company serves patients and its health care customers with products and services including heart valves, cardiac rhythm management systems, specialty catheters, and other cardiovascular devices.

Boston Scientific Corporation (NYSE:BSX): On 06/30/2011, Millennium Management reported holding 2,491,320 shares with a market value of $17,215,021. This comprised 0.16% of the total portfolio. On 09/30/2011, Millennium Management reported holding 4,301,491 shares with a market value of $25,421,811. This comprised 0.3% of the total portfolio. The net change in shares for this position over the two quarters is 1,810,171. About Company: Boston Scientific Corporation develops, manufactures, and markets minimally invasive medical devices. The Company’s products are used in interventional cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy, urology, gynecology and neuromodulation.

Dendreon Corp. (NASDAQ:DNDN): On 06/30/2011, Millennium Management reported holding 93,357 shares with a market value of $3,682,000. This comprised 0.03% of the total portfolio. On 09/30/2011, Millennium Management reported holding 2,673,625 shares with a market value of $24,062,625. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 2,580,268. About Company: Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body’s key defense against cancer.

Allergan Inc. (NYSE:AGN): On 06/30/2011, Millennium Management reported holding 179,170 shares with a market value of $14,915,903. This comprised 0.14% of the total portfolio. On 09/30/2011, Millennium Management reported holding 290,779 shares with a market value of $23,954,373. This comprised 0.28% of the total portfolio. The net change in shares for this position over the two quarters is 111,609. About Company: Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.

Aetna Inc. (NYSE:AET): On 06/30/2011, Millennium Management reported holding 377,006 shares with a market value of $16,622,195. This comprised 0.15% of the total portfolio. On 09/30/2011, Millennium Management reported holding 608,912 shares with a market value of $22,127,862. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is 231,906. About Company: Aetna Inc. is a diversified health care benefits company that provides healthcare and related benefits, serving health care members, dental members, and group insurance customers. The Company offers medical, pharmacy, dental, behavioral health, group life and disability plans, and medical management capabilities and health care management services for Medicaid plans.

Baxter International Inc. (NYSE:BAX): On 06/30/2011, Millennium Management reported holding 382,520 shares with a market value of $22,832,618. This comprised 0.21% of the total portfolio. On 09/30/2011, Millennium Management reported holding 390,613 shares with a market value of $21,929,014. This comprised 0.26% of the total portfolio. The net change in shares for this position over the two quarters is 8,093. About Company: Baxter International Inc. develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. The Company’s products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors’ offices, and research laboratories.

Hospira Inc. (NYSE:HSP): On 06/30/2011, Millennium Management reported holding 46,092 shares with a market value of $2,611,573. This comprised 0.02% of the total portfolio. On 09/30/2011, Millennium Management reported holding 537,479 shares with a market value of $19,886,723. This comprised 0.23% of the total portfolio. The net change in shares for this position over the two quarters is 491,387. About Company: Hospira, Inc. is a global specialty pharmaceutical and medication delivery company. The Company’s product portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management systems.

(Note: Data regarding Millennium Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>